数据在全球卫生中的再利用:政策,资金和研究参与者的观点
Naomi Waithira1,2, Evelyne Kestelyn3,4, Mavuto Mukaka3,2
1Centre for Tropical Medicine and Global Health, University of Oxford Nuffield Department of Medicine, Oxford, UK naomi@tropmedres.ac.
BMJ global health
|March 4, 2026
概括
单单要求数据共享是不足以在低收入和中等收入国家 (LMICs) 产生影响的. 政策需要资源用于数据策划,元数据和健康影响的激励措施,以及信任和利益共享.
科学领域:
- 卫生研究 卫生研究 卫生研究
- 数据科学数据科学数据科学
- 政策研究 政策研究
背景情况:
- 有越来越多的数据共享任务存在,但对共享临床数据的再利用及其对科学和政策的影响的理解是有限的.
- 现有的研究主要涉及数据获取,不太关注影响数据分析和随后的科学或政策结果的因素.
研究的目的:
- 探索共享临床研究数据再利用的动机,挑战和推动因素.
- 了解二次数据分析对卫生政策和科学进步的影响,特别是在低收入和中等收入国家 (LMICs).
主要方法:
- 与22名关键信息人进行半结构化采访,包括研究人员,政策制定者以及资金和制药组织的员工.
- 用演和归纳编码对面试数据进行专题分析,并遵守"报告定性研究综合标准" (COREQ) 框架.
主要成果:
- 二次数据分析偶尔会影响LMICs的临床指导方针和政策,包括告知WHO建议和国家COVID-19反应.
- 由于不完整的元数据和不充分的数据策划,共享数据往往没有准备好进行分析,这阻碍了重复使用.
- 数据贡献者之间的不信任以及学术界关注出版而不是健康影响限制了利用有价值的数据集,冒着选择偏见和排除代表性不足的群体的风险.
结论:
- 数据共享任务需要补充数据策划资源,机器可操作的元数据,以及对影响驱动的研究的激励措施,以便在LMICs中有效.
- 通过承认数据贡献者和建立公平,透明的利益分享机制来建立信任,对于最大限度地提高共享数据的影响至关重要.
相关概念视频
01:28International Nursing Organizations II
1.4K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.4K
01:26Methods Of Healthcare Delivery System
4.2K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
4.2K
01:26Principles of Disease Surveillance
724
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
724
01:30Primary Healthcare Services
2.6K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.6K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
626
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
626
01:56Ethics in Research
26.0K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
26.0K